Skip to main content
Premium Trial:

Request an Annual Quote

This Week in the British Journal of Cancer: Aug 30, 2011

Premium

In the British Medical Journal this week, UK researchers present findings from an effort to develop predictor models to improve prognostication for advanced cancer patients. The researchers analyzed data from 1,018 patients with locally advanced or metastatic cancer, who were no longer being treated. They found that 11 core variables — pulse rate, general health status, mental test score, performance status, presence of anorexia, presence of any site of metastatic disease, presence of liver metastases, C reactive protein, white blood count, platelet count, and urea — independently predicted both two-week and two-month survival. The team also found four variables that had prognostic significance only for two-week survival and eight variables that predicted two-month survival. After creating predictor models using these variables and applying them to two groups of cancer patients, the team found that its models "performed as well as, or better than, clinicians' estimates of survival."

In a related editorial in the British Medical Journal, Memorial Sloan-Kettering Cancer Center's Paul Glare says that while prognostic tools are important for helping to determine patient survival, they shouldn't be applied blindly. When the Lockerbie bomber was released from prison in 2009, it was partly because his doctors had said he only had a few months to live because of his advanced prostate cancer — however, he is still alive today, Glare says. Prognosis is a "new science" in palliative care, he adds, and it involves both formulating the prediction and communicating it to the patients. There is guidance available for physicians who want to determine a prognosis, but some are inaccurate. The above study overcomes many of the difficulties of previous methodologies, Glare says, but the downside is that the new models are too difficult to use at the bedside and require some calculation. "Ultimately, even a state of the art prognostic tool ... will often be inaccurate," Glare says. "Until this inherent inaccuracy is mitigated, doctors will continue to resist prognosticating; those who do will be scorned by their colleagues and accused of 'playing God.'"

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.